Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00458978
Status:
COMPLETED
Last Update Posted:
2015-05-05
First Post:
2007-04-09
Brief Title:
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Untreated Metastatic Squamous Cell Carcinoma to Neck With Occult Primary |
| Recurrent Hypopharyngeal Squamous Cell Carcinoma |
| Recurrent Laryngeal Squamous Cell Carcinoma |
| Recurrent Laryngeal Verrucous Carcinoma |
| Recurrent Lip and Oral Cavity Squamous Cell Carcinoma |
| Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary |
| Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma |
| Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma |
| Recurrent Oral Cavity Verrucous Carcinoma |
| Recurrent Oropharyngeal Squamous Cell Carcinoma |
| Recurrent Salivary Gland Carcinoma |
| Salivary Gland Squamous Cell Carcinoma |
| Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary |
| Stage IV Hypopharyngeal Squamous Cell Carcinoma |
| Stage IV Laryngeal Squamous Cell Carcinoma |
| Stage IV Laryngeal Verrucous Carcinoma |
| Stage IV Lip and Oral Cavity Squamous Cell Carcinoma |
| Stage IV Major Salivary Gland Carcinoma |
| Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma |
| Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma |
| Stage IV Oral Cavity Verrucous Carcinoma |
| Stage IV Oropharyngeal Squamous Cell Carcinoma |
| Tongue Carcinoma |
Keywords: